NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
10/07/2025
Back to search
Official data from USPTO
RENADYL
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
20
Latest update
10/08/2025
Trademark type
Word
Nice classes
5
Filing date
05/02/2024
Registration date
10/07/2025
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
10/07/2025
Last transaction
10/08/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Foreign priority
First use anywhere
2011-12-00
First use in commerce
2011-12-00
Drawing code
4
Owner type
16
Owner location
Newtown Square, PA
Examiner
BURKE,JUSTINE N
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
Kibow Biotech LLC
Representatives
LUNA M. SAMMAN ARENTFOX SCHIFF LLP
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Nutritional supplements for use in treating and helping maintain renal function and kidney healthwith the exclusion of prescription medicines
Publications
History of USPTO decisions and trademark events.
20 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
10/07/2025
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
10/03/2025
TMBN
TTAB RELEASE CASE TO TRADEMARKS
09/16/2025
OP.T
OPPOSITION TERMINATED NO. 999999
09/16/2025
OP.D
OPPOSITION DISMISSED NO. 999999
09/16/2025
ETOP
EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
06/08/2025
OP.I
OPPOSITION INSTITUTED NO. 999999
06/07/2025
ETOF
EXTENSION OF TIME TO OPPOSE RECEIVED
12/23/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
12/10/2024
PUBO
PUBLISHED FOR OPPOSITION
12/10/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
12/04/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
11/18/2024
XAEC
EXAMINER'S AMENDMENT ENTERED
11/18/2024
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
11/18/2024
GNEA
EXAMINERS AMENDMENT E-MAILED
11/18/2024
CNEA
EXAMINERS AMENDMENT -WRITTEN
11/18/2024
DOCK
ASSIGNED TO EXAMINER
11/18/2024
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
05/02/2024
NWAP
NEW APPLICATION ENTERED
05/02/2024
Continuous trademark protection
Get notified about every new filing that threatens RENADYL or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.